A) The ease of obtaining stem cells from adults. B) The uncontroversial ethical implications. C) The lack of potential applications. D) The use of embryonic stem cells.
A) Ignoring public opinions and concerns. B) Speed of research progress above all else. C) Funding from private corporations only. D) Ethical guidelines and regulations.
A) To eliminate competition among research institutions. B) To avoid sharing scientific breakthroughs. C) To address regulatory disparities and ensure ethical standards. D) To hinder progress in the field.
A) Excluding patient advocates from the research process. B) Creating financial barriers to stem cell research. C) Developing international policy guidance on stem cell research. D) Promoting unregulated stem cell experimentation.
A) Speed up the aging process in patients. B) Replace traditional medicine for all illnesses. C) Repair, replace, and regenerate damaged cells or tissues. D) Create artificial intelligence using stem cells.
A) To ignore public opinions and concerns. B) To address diverse views on ethics, religious beliefs, and values that impact policy decisions. C) To prioritize scientific progress over societal implications. D) To only focus on economic factors.
A) Opposing all forms of medical research involving stem cells. B) Providing expertise on ethical implications and considerations. C) Advocating for unrestricted research with no ethical oversight. D) Serving as decision-makers for all stem cell research projects.
A) Totipotent cells can develop into any type of cell, including embryonic tissues, while pluripotent cells can develop into almost any type of cell. B) There is no difference between the two types of stem cells. C) Pluripotent cells are more versatile than totipotent cells. D) Pluripotent cells can only divide a limited number of times. |